Astrocyte immune responses in epilepsy

GLIA

Volumn 60, Issue 8, 2012, Pages 1258-1268

  Aronica, Eleonora ^a,b   Ravizza, Teresa ^c   Zurolo, Emanuele ^a   Vezzani, Annamaria ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Astrocytes; Cytokines; Epilepsy; Human; Inflammation; Rodents

Indexed keywords

CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTICONVULSANT ACTIVITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ASTROCYTE; CELLULAR IMMUNITY; ENCEPHALITIS; EPILEPSY; EPILEPTOGENESIS; GENE EXPRESSION REGULATION; HIPPOCAMPAL SCLEROSIS; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MICROGLIA; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; TEMPORAL LOBE EPILEPSY;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; CYTOKINES; ENCEPHALITIS; EPILEPSY; HUMANS;

EID: 84862312999     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22312     Document Type: Review

References (152)

1. Abbracchio MP, Ceruti S. 2007. P1 receptors and cytokine secretion. Purinergic Signal 3: 13-25.
2. Akassoglou K, Probert L, Kontogeorgos G, Kollias G. 1997. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 158: 438-445.
3. Akin D, Ravizza T, Maroso M, Carcak N, Eryigit T, Vanzulli I, Aker RG, Vezzani A, Yilmaz FO. 2011. IL-1beta is induced in reactive astrocytes in the somatosensory cortex of rats with genetic absence epilepsy at the onset of spike-and-wave discharges, and contributes to their occurrence. Neurobiol Dis 44: 259-269.
4. Allan SM, Tyrrell PJ, Rothwell NJ. 2005. Interleukin-1 and neuronal injury. Nat Rev Immunol 5: 629-640.
5. Aloisi F, Ria F, Penna G, Adorini L. 1998. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 160: 4671-4680.
6. Aloisi F, Ria F, Adorini L. 2000a. Regulation of T-cell responses by CNS antigen-presenting cells: Different roles for microglia and astrocytes. Immunol Today 21: 141-147.
7. Aloisi F, Serafini B, Adorini L. 2000b. Glia-T cell dialogue. J Neuroimmunol 107: 111-117.
8. Aloisi F. 2001. Immune function of microglia. Glia 36: 165-179.
9. Amor S, Puentes F, Baker D, van der Valk P. 2010. Inflammation in neurodegenerative diseases. Immunology 129: 154-169.
10. Andjelkovic AV, Kerkovich D, Pachter JS. 2000. Monocyte:astrocyte interactions regulate MCP-1 expression in both cell types. J Leukoc Biol 68: 545-552.
11. Aronica E, Boer K, Becker A, Redeker S, Spliet WG, van Rijen PC, Wittink F, Breit T, Wadman WJ, Lopes da Silva FH, Troost D, Gorter JA. 2008. Gene expression profile analysis of epilepsy-associated gangliogliomas. Neuroscience 151: 272-292.
12. Aronica E, Boer K, van Vliet EA, Baayen JC, Redeker S, Spliet WGM, Lopes da Silva FH, Wadman WJ, Troost D, Gorter JA. 2007. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 26: 497-511.
13. Aronica E, Crino PB. 2011. Inflammation in epilepsy: Clinical observations. Epilepsia 52(Suppl 3): 26-32.
14. Aronica E, Fluiter K, Iyer A, Zurolo E, Vreijling J, van Vliet EA, Baayen JC, Gorter JA. 2010. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 31: 1100-1107.
15. Aronica E, Gorter J. 2007. Gene expression profile in temporal lobe epilepsy. Neuroscientist 13: 1-9.
16. Aronica E, Gorter JA, Ijlst-Keizers H, Rozemuller AJ, Yankaya B, Leenstra S, Troost D. 2003. Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: Opposite regulation of glutamate transporter proteins. Eur J Neurosci 17: 2106-2118.
17. Aronica E, Gorter JA, Rozemuller AJ, Yankaya B, Troost D. 2005a. Activation of metabotropic glutamate receptor 3 enhances interleukin (IL)-1beta-stimulated release of IL-6 in cultured human astrocytes. Neuroscience 130: 927-933.
18. Aronica E, Gorter JA, Rozemuller AJ, Yankaya B, Troost D. 2005b. Interleukin-1 beta down-regulates the expression of metabotropic glutamate receptor 5 in cultured human astrocytes. J Neuroimmunol 160: 188-194.
19. Aronica E, van Vliet EA, Mayboroda OA, Troost D, da Silva FH, Gorter JA. 2000. Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy. Eur J Neurosci 12: 2333-2344.
20. Aronica E, Zurolo E, Iyer A, de Groot M, Anink J, Carbonell C, van Vliet EA, Baayen JC, Boison D, Gorter JA. 2011b. Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy. Epilepsia 52: 1645-1655.
21. Balosso S, Ravizza T, Perego C, Peschon J, Campbell IL, De Simoni MG, Vezzani A. 2005. Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann Neurol 57: 804-812.
22. Barnum SR, Jones JL. 1995. Differential regulation of C3 gene expression in human astroglioma cells by interferon-gamma and interleukin-1 beta. Neurosci Lett 197: 121-124.
23. Bauer B, Hartz AM, Pekcec A, Toellner K, Miller DS, Potschka H. 2008. Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Mol Pharmacol 73: 1444-1453.
24. Bauer J, Elger CE, Hans VH, Schramm J, Urbach H, Lassmann H, Bien CG. 2007. Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann Neurol 62: 67-80.
25. Beattie MS, Hermann GE, Rogers RC, Bresnahan JC. 2002. Cell death in models of spinal cord injury. Prog Brain Res 137: 37-47.
26. Becher B, Prat A, Antel JP. 2000. Brain-immune connection: Immuno-regulatory properties of CNS-resident cells. Glia 29: 293-304.
27. Bellinger FP, Madamba S, Siggins GR. 1993. Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 628: 227-234.
28. Benarroch EE. 2007. Tissue plasminogen activator: Beyond thrombolysis. Neurology 69: 799-802.
29. Bernardino L, Ferreira R, Cristovao AJ, Sales F, Malva JO. 2005. Inflammation and neurogenesis in temporal lobe epilepsy. Curr Drug Targets CNS Neurol Disord 4: 349-360.
30. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, et al. 2001. CXCR4-activated astrocyte glutamate release via TNFalpha: Amplification by microglia triggers neurotoxicity. Nat neurosci 4: 702-710.
31. Bianchi ME, Manfredi AA. 2009. Immunology. Dangers in and out. Science 323: 1683-1684.
32. Blumcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A, Jacques TS, Avanzini G, Barkovich AJ, Battaglia G, et al. 2011. The clinico-pathological spectrum of Focal Cortical Dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostics Commission. Epilepsia 52: 158-174.
33. Blümcke I, Vinters HV, Armstrong D, Aronica E, Thom M, Spreafico R. 2009. Malformations of cortical development and epilepsies: Neuropathological findings with emphasis on Focal Cortical Dysplasia. Epileptic Disord 11: 181-193.
34. Boer K, Crino PB, Gorter JA, Nellist M, Jansen FE, Spliet WG, van Rijen PC, Wittink F, Breit T, Troost D, et al. 2010. Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol 20: 704-719.
35. Boer K, Troost D, Spliet WG, van Rijen PC, Gorter JA, Aronica E. 2008. Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB. Acta Neuropat 115: 683-696.
36. Boison D. 2010. Adenosine dysfunction and adenosine kinase in epileptogenesis. Open Neurosci J 4: 93-101.
37. Bonifati DM, Kishore U. 2007. Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 44: 999-1010.
38. Boon CJ, van de Kar NC, Klevering BJ, Keunen JE, Cremers FP, Klaver CC, Hoyng CB, Daha MR, den Hollander AI. 2009. The spectrum of phenotypes caused by variants in the CFH gene. Mol Immunol 46: 1573-1594.
39. Byrnes KR, Loane DJ, Faden AI. 2009. Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics 6: 94-107.
40. Carmignoto G, Fellin T. 2006. Glutamate release from astrocytes as a non-synaptic mechanism for neuronal synchronization in the hippocampus. J Physiol 99: 98-102.
41. Casamenti F, Prosperi C, Scali C, Giovannelli L, Colivicchi MA, Faussone-Pellegrini MS, Pepeu G. 1999. Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: Implications for Alzheimer's disease. Neuroscience 91: 831-842.
42. Chew LJ, Takanohashi A, Bell M. 2006. Microglia and inflammation: Impact on developmental brain injuries. Ment Retard Dev Disabil Res Rev 12: 105-112.
43. Cohly HH, Panja A. 2005. Immunological findings in autism. Int Rev Neurobiol 71: 317-341.
44. Cornet A, Bettelli E, Oukka M, Cambouris C, Avellana-Adalid V, Kosmatopoulos K, Liblau RS. 2000. Role of astrocytes in antigen presentation and naive T-cell activation. J Neuroimmunol 106: 69-77.
45. Crack PJ, Bray PJ. 2007. Toll-like receptors in the brain and their potential roles in neuropathology. Immunol Cell Biol 85: 476-480.
46. Crespel A, Coubes P, Rousset MC, Brana C, Rougier A, Rondouin G, Bockaert J, Baldy-Moulinier M, Lerner-Natoli M. 2002. Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res 952: 159-169.
47. Cross AH, Ku G. 2000. Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis. J Neuroimmunol 110: 76-82.
48. Cui JG, Li YY, Zhao Y, Bhattacharjee S, Lukiw WJ. 2010. Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J Biol Chem 285: 38951-38960.
49. D'Antoni S, Berretta A, Bonaccorso CM, Bruno V, Aronica E, Nicoletti F, Catania MV. 2008. Metabotropic glutamate receptors in glial cells. Neurochem Res 33: 2436-2443.
50. De Keyser J, Zeinstra E, Frohman E. 2003. Are astrocytes central players in the pathophysiology of multiple sclerosis? Arch Neurol 60: 132-136.
51. De Simoni MG, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F, De Luigi A, Garattini S, Vezzani A. 2000. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 12: 2623-2633.
52. Desjardins P, Sauvageau A, Bouthillier A, Navarro D, Hazell AS, Rose C, Butterworth RF. 2003. Induction of astrocytic cyclooxygenase-2 in epileptic patients with hippocampal sclerosis. Neurochem Int 42: 299-303.
53. Dinarello CA. 2004. Infection, fever, and exogenous and endogenous pyrogens: Some concepts have changed. J Endotoxin Res 10: 201-222.
54. Dong Y, Benveniste EN. 2001. Immune function of astrocytes. Glia 36: 180-190.
55. Dubè C, Vezzani A, Behrens M, Bartfai T, Baram TZ. 2005. Interleukin-1beta contributes to the generation of experimental febrile seizures [comment]. Ann Neurol 57: 152-155.
56. Farina C, Aloisi F, Meinl E. 2007. Astrocytes are active players in cerebral innate immunity. Trends Immunol 28: 138-145.
57. Farrell MA, Droogan O, Secor DL, Poukens V, Quinn B, Vinters HV. 1995. Chronic encephalitis associated with epilepsy: Immunohistochemical and ultrastructural studies. Acta Neuropathol 89: 313-321.
58. Fernandez-Monreal M, Lopez-Atalaya JP, Benchenane K, Leveille F, Cacquevel M, Plawinski L, MacKenzie ET, Bu G, Buisson A, Vivien D. 2004. Is tissue-type plasminogen activator a neuromodulator? Mol Cell Neurosci 25: 594-601.
59. Fischer W, Appelt K, Grohmann M, Franke H, Norenberg W, Illes P. 2009. Increase of intracellular Ca2+ by P2X and P2Y receptor-subtypes in cultured cortical astroglia of the rat. Neuroscience 160: 767-783.
60. Friedman A, Dingledine R. 2011. Molecular cascades that mediate the influence of inflammation on epilepsy. Epilepsia 52(Suppl 3): 33-39.
61. Friedman A, Kaufer D, Heinemann U. 2009. Blood-brain barrier breakdown-inducing astrocytic transformation: Novel targets for the prevention of epilepsy. Epilepsy Res 85: 142-149.
62. Galic MA, Riazi K, Henderson AK, Tsutsui S, Pittman QJ. 2009. Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol Dis 36: 343-351.
63. Gantier MP. 2010. New perspectives in MicroRNA regulation of innate immunity. J Interferon Cytokine Res 30: 283-289.
64. Girvin AM, Gordon KB, Welsh CJ, Clipstone NA, Miller SD. 2002. Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells. Blood 99: 3692-3701.
65. Glynn MW, Elmer BM, Garay PA, Liu XB, Needleman LA, El-Sabeawy F, McAllister AK. 2011. MHCI negatively regulates synapse density during the establishment of cortical connections. Nat Neurosci 14: 442-451.
66. Gobin SJ, Montagne L, Van Zutphen M, Van Der Valk P, Van Den Elsen PJ, De Groot CJ. 2001. Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions. Glia 36: 68-77.
67. Gomes CV, Kaster MP, Tome AR, Agostinho PM, Cunha RA. 2011. Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration. Biochim Biophys Acta 1808: 1380-1399.
68. Gorter JA, Van Vliet E, Aronica E, Rauwerda H, Breit T, Lopes da Silva FH, Wadman WJ. 2006. Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J Neurosci 26: 11083-11110.
69. Graeber MB, Streit WJ. 1990. Microglia: Immune network in the CNS. Brain Pathol 1: 2-5.
70. Gravanis I, Tsirka SE. 2005. Tissue plasminogen activator and glial function. Glia 49: 177-183.
71. Griffiths MR, Neal JW, Fontaine M, Das T, Gasque P. 2009. Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis. J Immunol 182: 4368-4377.
72. Hajishengallis G, Lambris JD. 2010. Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol 31: 154-163.
73. Harrè EM, Galic MA, Mouihate A, Noorbakhsh F, Pittman QJ. 2008. Neonatal inflammation produces selective behavioural deficits and alters N-methyl-D-aspartate receptor subunit mRNA in the adult rat brain. Eur J Neurosci 27: 644-653.
74. Hasko G, Pacher P, Vizi ES, Illes P. 2005. Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci 26: 511-516.
75. Hayakawa K, Arai K, Lo EH. 2010. Role of ERK map kinase and CRM1 in IL-1beta-stimulated release of HMGB1 from cortical astrocytes. Glia 58: 1007-1015.
76. Heida JG, Pittman QJ. 2005. Causal links between brain cytokines and experimental febrile convulsions in the rat. Epilepsia 46: 1906-1913.
77. Hewett SJ, Csernansky CA, Choi DW. 1994. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 13: 487-494.
78. Holtman L, van Vliet EA, van Schaik R, Queiroz CM, Aronica E, Gorter JA. 2009. Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy. Epilepsy Res 84: 56-66.
79. Hu S, Sheng WS, Ehrlich LC, Peterson PK, Chao CC. 2000. Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 7: 153-159.
80. Ivens S, Kaufer D, Flores LP, Bechmann I, Zumsteg D, Tomkins O, Seiffert E, Heinemann U, Friedman A. 2007. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130: 535-547.
81. Iyer AM, Zurolo E, Boer K, Baayen JC, Giangaspero F, Arcella A, Di Gennaro GC, Esposito V, Spliet WG, van Rijen PC, et al. 2010. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies. Neuroscience 167: 929-945.
82. Kawai T, Akira S. 2007. Signaling to NF-κB by Toll-like receptors Trends Mol Med 13: 460-469.
83. Khurgel M, Switzer RCIII, Teskey GC, Spiller AE, Racine RJ, Ivy GO. 1995. Activation of astrocytes during epileptogenesis in the absence of neuronal degeneration. Neurobiol Dis 2: 23-35.
84. Kielian T. 2006. Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res 83: 711-730.
85. Kim SK, Wang KC, Hong SJ, Chung CK, Lim SY, Kim YY, Chi JG, Kim CJ, Chung YN, Kim HJ, et al. 2003. Gene expression profile analyses of cortical dysplasia by cDNA arrays. Epilepsy Res 56: 175-183.
86. Kulkarni SK, Dhir A. 2009. Cyclooxygenase in epilepsy: From perception to application. Drugs Today 45: 135-154.
87. Lai AY, Swayze RD, El-Husseini A, Song C. 2006. Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons. JJ Neuroimmunol 175: 97-106.
88. Liu JS, John GR, Sikora A, Lee SC, Brosnan CF. 2000. Modulation of interleukin-1beta and tumor necrosis factor alpha signaling by P2 purinergic receptors in human fetal astrocytes. J Neurosci 20: 5292-5299.
89. Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, Rossetti C, Molteni M, Manfredi AA, et al. 2010. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nature Med 1 16: 413-419.
90. Maroso M, Balosso S, Ravizza T, Liu J, Bianchi ME, Vezzani A. 2011. Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: The importance of IL-1beta and high-mobility group box 1. J Int Med 270: 319-326.
91. Matute C, Cavaliere F. 2011. Neuroglial interactions mediated by purinergic signalling in the pathophysiology of CNS disorders. Semin Cell Dev Biol 22: 252-259.
92. McNaull BB, Todd S, McGuinness B, Passmore AP. 2010. Inflammation and anti-inflammatory strategies for Alzheimer's disease--A mini-review. Gerontology 56: 3-14.
93. Meeuwsen S, Persoon-Deen C, Bsibsi M, Ravid R, van Noort JM. 2003. Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia 43: 243-253.
94. Morin-Brureau M, Lebrun A, Rousset MC, Fagni L, Bockaert J, de Bock F, Lerner-Natoli M. 2011. Epileptiform activity induces vascular remodeling and zonula occludens 1 downregulation in organotypic hippocampal cultures: Role of VEGF signaling pathways. J Neurosci 31: 10677-10688.
95. Muller S, Ronfani L, Bianchi ME. 2004. Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J Int Med 255: 332-343.
96. O'Donnell E, Vereker E, Lynch MA. 2000. Age-related impairment in LTP is accompanied by enhanced activity of stress-activated protein kinases: Analysis of underlying mechanisms. Eur J Neurosci 12: 345-352.
97. O'Neill LA. 2008. The interleukin-1 receptor/Toll-like receptor superfamily: 10 Years of progress. Immunol Rev 226: 10-18.
98. O'Neill LA, Dinarello CA. 2000. The IL-1 receptor/toll-like receptor superfamily: Crucial receptors for inflammation and host defense. Immunol Today 21: 206-209.
99. Oeckinghaus A, Hayden MS, Ghosh S. 2011. Crosstalk in NF-kappaB signaling pathways. Nat Immunol 12: 695-708.
100. Orlova KA, Crino PB. 2010. The tuberous sclerosis complex. Ann NY Acad Sci 1184: 87-105.
101. Panenka W, Jijon H, Herx LM, Armstrong JN, Feighan D, Wei T, Yong VW, Ransohoff RM, MacVicar BA. 2001. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J Neurosci 21: 7135-7142.
102. Parker WE, Orlova KA, Heuer GG, Baybis M, Aronica E, Frost M, Wong M, Crino PB. 2011. Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex. Am J Pathol 178: 296-305.
103. Pedrazzi M, Patrone M, Passalacqua M, Ranzato E, Colamassaro D, Sparatore B, Pontremoli S, Melloni E. 2007. Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling. J Immunol 179: 8525-8532.
104. Plata-Salaman CR, Ffrench-Mullen JM. 1994. Interleukin-1 beta inhibits Ca2+ channel currents in hippocampal neurons through protein kinase C. Eur J Pharmacol 266: 1-10.
105. Probert L, Plows D, Kontogeorgos G, Kollias G. 1995. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Eur J Immunol 25: 1794-1797.
106. Quinn SR, O'Neill LA. 2011. A trio of microRNAs that control Toll-like receptor signalling. Int Immunol 23: 421-425.
107. Ravizza T, Balosso S, Vezzani A. 2011. Inflammation and prevention of epileptogenesis. Neurosci lett 497: 223-230.
108. Ravizza T, Boer K, Redeker S, Spliet WG, van Rijen PC, Troost D, Vezzani A, Aronica E. 2006a. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 24: 128-143.
109. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A. 2008a. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: Evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29: 142-160.
110. Ravizza T, Lucas SM, Balosso S, Bernardino L, Ku G, Noe' F, Malva J, Rande JC, Allan S, Vezzani A. 2006b. Inactivation of caspase-1 in rodent brain: A novel anticonvulsive strategy. Epilepsia 47: 1160-1168.
111. Ravizza T, Noe F, Zardoni D, Vaghi V, Sifringer M, Vezzani A. 2008b. Interleukin converting enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiol Dis 31: 327-333.
112. Riazi K, Galic MA, Pittman QJ. 2010. Contributions of peripheral inflammation to seizure susceptibility: Cytokines and brain excitability. Epilepsy Research 89: 34-42.
113. Rigau V, Morin M, Rousset MC, de Bock F, Lebrun A, Coubes P, Picot MC, Baldy-Moulinier M, Bockaert J, Crespel A, et al. 2007a. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain 130: 1942-1956.
114. Rodgers KM, Hutchinson MR, Northcutt A, Maier SF, Watkins LR, Barth DS. 2009. The cortical innate immune response increases local neuronal excitability leading to seizures. Brain 132: 2478-2486.
115. Samadani U, Judkins AR, Akpalu A, Aronica E, Crino PB. 2007. Differential cellular gene expression in ganglioglioma. Epilepsia 48: 646-653.
116. Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A, Besedovsky HO. 1998. A neuromodulatory role of interleukin-1beta in the hippocampus. Ann NY Acad Sci, 95: 7778-7783.
117. Schoch HJ, Fischer S, Marti HH. 2002. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125: 2549-2557.
118. Schwartz M, Kipnis J. 2011. A conceptual revolution in the relationships between the brain and immunity. Brain Behav Immun 25: 817-819.
119. Seifert G, Carmignoto G, Steinhauser C. 2010. Astrocyte dysfunction in epilepsy. Brain Res Rev 63: 212-221.
120. Sheedy FJ, O'Neill LA. 2008. Adding fuel to fire: Micrornas as a new class of mediators of inflammation. Ann Rheum Dis 67(Suppl 3): iii50-iii55.
121. Sheng WS, Hu S, Min X, Cabral GA, Lokensgard JR, Peterson PK. 2005. Synthetic cannabinoid WIN55, 212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia 49: 211-219.
122. Sofroniew MV, Vinters HV. 2010. Astrocytes: Biology and pathology. Acta Neuropathol 119: 7-35.
123. Sonkoly E, Stahle M, Pivarcsi A. 2008. MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammation. Sem Cancer Biol 18: 131-140.
124. Sosunov AA, Wu X, Weiner HL, Mikell CB, Goodman RR, Crino PD, McKhann GMII. 2008. Tuberous sclerosis: A primary pathology of astrocytes? Epilepsia 49(Suppl 2): 53-62.
125. Spencer SJ, Heida JG, Pittman QJ. 2005. Early life immune challenge--Effects on behavioural indices of adult rat fear and anxiety. Behav Brain Res 164: 231-238.
126. Stellwagen D, Beattie EC, Seo JY, Malenka RC. 2005. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 25: 3219-3228.
127. Steward O, Torre ER, Tomasulo R, Lothman E. 1992. Seizures and the regulation of astroglial gene expression. Epilepsy Res 7: 197-209.
128. Taganov KD, Boldin MP, Chang KJ, Baltimore D. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103: 12481-12486.
129. Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J, Oberheim N, Lou N, Wang X, Zielke HR, et al. 2005. An astrocytic basis of epilepsy. Nat Med 11: 973-981.
130. Traugott U, Raine CS. 1985. Multiple sclerosis. Evidence for antigen presentation in situ by endothelial cells and astrocytes. J Neurol Sci 69: 365-370.
131. van Vliet EA, da Costa Araújo S, Redeker S, van Schaik R, Aronica E, Gorter JA. 2007. Long-lasting increased permeability of the blood-brain barrier may contribute to seizure progression in temporal lobe epilepsy. Brain 130: 521-534.
132. van Vliet EA, Zibell G, Pekcec A, Schlichtiger J, Edelbroek PM, Holtman L, Aronica E, Gorter JA, Potschka H. 2009. COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats. Neuropharmacology 58: 404-412.
133. Veerhuis R, Janssen I, De Groot CJ, Van Muiswinkel FL, Hack CE, Eikelenboom P. 1999. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor. Exp Neurol 160: 289-299.
134. Vezzani A, Aronica E, Mazarati A, Pittman QJ. Epilepsy and brain inflammation. Exp Neurol 2011. [Epub ahead of print]. http://dx.doi.org/10.1016/j.expneurol.2011.09.033.
135. Vezzani A, Balosso S, Maroso M, Zardoni D, Noè F, Ravizza T. 2010. ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. Curr Opin Investig Drugs 11: 43-50.
136. Vezzani A, Balosso S, Ravizza T. 2008a. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 22: 797-803.
137. Vezzani A, Baram TZ. 2007. New roles for interleukin-1beta in the mechanisms of epilepsy. Epilepsy Curr 7: 45-50.
138. Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, De Simoni MG. 1999. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: Functional evidence for enhancement of electrographic seizures. J Neurosci 19: 5054-5065.
139. Vezzani A, French J, Bartfai T, Baram TZ. 2011b. The role of inflammation in epilepsy. Nat Rev Neurol 7: 31-40.
140. Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T. 2011c. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 25: 1281-1289.
141. Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T. 2011d. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 25: 1281-1289.
142. Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A, De Simoni MG, Sperk G, Andell-Jonsson S, Lundkvist J, et al. 2000. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA 97: 11534-11539.
143. Vezzani A, Ravizza T, Balosso S, Aronica E. 2008b. Glia as a source of cytokines: Implications for neuronal excitability and survival. Epilepsia 49(Suppl 2): 24-32.
144. Viviani B, Bartesaghi S, Corsini E, Galli CL, Marinovich M. 2004. Cytokines role in neurodegenerative events. Toxicol Lett 149: 85-89.
145. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, et al. 2003. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci 23: 8692-8700.
146. Weber F, Meinl E, Aloisi F, Nevinny-Stickel C, Albert E, Wekerle H, Hohlfeld R. 1994. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis. Brain 117: 59-69.
147. Wetherington J, Serrano G, Dingledine R. 2008. Astrocytes in the epileptic brain. Neuron 58: 168-178.
148. Wieser HG. 2004. ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 45: 695-714.
149. Wong M. 2008. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia 49: 8-21.
150. Wu Y, Wang X, Mo X, Xi Z, Xiao F, Li J, Zhu X, Luan G, Wang Y, Li Y, et al. 2008. Expression of monocyte chemoattractant protein-1 in brain tissue of patients with intractable epilepsy. Clin Neuropathol 27: 55-63.
151. Ye ZC, Sontheimer H. 1996. Cytokine modulation of glial glutamate uptake: A possible involvement of nitric oxide. Neuroreport 7: 2181-2185.
152. Zurolo E, Iyer A, Maroso M, Carbonell C, Anink JJ, Ravizza T, Fluiter K, Spliet WG, van Rijen PC, Vezzani A, et al. 2011. Activation of toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. Brain 134: 1015-1032.